Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Daily News

Making Sense of Masters Athletes’ Cardiac Imaging: Expert Review

Michael O'Riordan

December 11, 2025

News Daily News

Risk of Another Event Remains High for Years After TIA, Minor Stroke

Todd Neale

March 26, 2025

News Daily News

‘Disproportionate’ Suicide/Self-Harm Signal With Semaglutide: WHO Database

Michael O'Riordan

August 21, 2024

News Daily News

Coronary CTA Should Be First When Assessing Stable CAD: Consensus Document

Yael L. Maxwell

September 10, 2020

News Daily News

The Color of Coronavirus: Large Burden of COVID-19 Borne by African Americans

Michael O'Riordan

June 12, 2020

News Daily News

Obesity Prevalence Triples in China Over 10-Year Span

Michael O'Riordan

October 28, 2019

News Daily News

Aspirin Should Play Limited Role in Primary Prevention: Review

Michael O'Riordan

November 27, 2018

News Conference News AHA 2018

New Cholesterol Guidelines Make Room for Non-Statin Therapy and CAC Screening

Michael O'Riordan

November 10, 2018

News Daily News

Do Not Screen Asymptomatic Adults For CVD With ECGs, Says USPSTF

Michael O'Riordan

June 12, 2018

News Daily News

Study Questions Incremental Benefit of Beta-Blockers After Acute MI

Michael O'Riordan

September 21, 2017

News

Mortality and CVD Decline in Patients With Diabetes, but Biggest Strides Seen for Nonfatal Outcomes

Michael O'Riordan

April 13, 2017

News Daily News

Yet Another Set of Hypertension Guidelines Sow Confusion Surrounding BP Targets in Older Patients

Michael O'Riordan

January 17, 2017

News Daily News

Liraglutide Leaps Over FDA Safety Hurdle, With Cardiovascular Mortality Reduction to Boot: LEADER

Michael O'Riordan

June 14, 2016

News Daily News

Estudio LEADER: Liraglutide se Salta la Valla de Seguridad de la FDA al Confirmarse un Descenso de la Mortalidad Cardiovascular

Michael O'Riordan

June 14, 2016

Advertisement

Making Sense of Masters Athletes’ Cardiac Imaging: Expert Review

Risk of Another Event Remains High for Years After TIA, Minor Stroke

‘Disproportionate’ Suicide/Self-Harm Signal With Semaglutide: WHO Database

Coronary CTA Should Be First When Assessing Stable CAD: Consensus Document

The Color of Coronavirus: Large Burden of COVID-19 Borne by African Americans

Obesity Prevalence Triples in China Over 10-Year Span

Aspirin Should Play Limited Role in Primary Prevention: Review

New Cholesterol Guidelines Make Room for Non-Statin Therapy and CAC Screening

Do Not Screen Asymptomatic Adults For CVD With ECGs, Says USPSTF

Study Questions Incremental Benefit of Beta-Blockers After Acute MI

Mortality and CVD Decline in Patients With Diabetes, but Biggest Strides Seen for Nonfatal Outcomes

Yet Another Set of Hypertension Guidelines Sow Confusion Surrounding BP Targets in Older Patients

Liraglutide Leaps Over FDA Safety Hurdle, With Cardiovascular Mortality Reduction to Boot: LEADER

Estudio LEADER: Liraglutide se Salta la Valla de Seguridad de la FDA al Confirmarse un Descenso de la Mortalidad Cardiovascular

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content